Application | Comment | Organism |
---|---|---|
synthesis | in vitro sequential glycosylations of the vancomycin aglycon catalyzed by the glycosyltransferases GtfE and GtfD and total synthesis of vancomycin and derivatives. For GtfE, presence of reductant tris(2-carboxyethyl)phosphine (TCEP, 2 mM) is crucial | Amycolatopsis orientalis |
Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli | Amycolatopsis orientalis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
CHAPS | - |
Amycolatopsis orientalis | |
Triton X-100 | - |
Amycolatopsis orientalis | |
Tween 20 | - |
Amycolatopsis orientalis |
Organic Solvent | Comment | Organism |
---|---|---|
DMSO | up to 10% v/v, tolerated | Amycolatopsis orientalis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Amycolatopsis orientalis | - |
- |
- |
Amycolatopsis orientalis ATCC 19795 | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | study on reaction after modification of the vancomycin aglycon. Modification at the N-terminus amine of vancomycin aglycon is well tolerated, whereas C-terminus modification with removal of the acidic carboxylic acid results in a slower, less effective initial glycosylation | Amycolatopsis orientalis | ? | - |
? | |
additional information | study on reaction after modification of the vancomycin aglycon. Modification at the N-terminus amine of vancomycin aglycon is well tolerated, whereas C-terminus modification with removal of the acidic carboxylic acid results in a slower, less effective initial glycosylation | Amycolatopsis orientalis ATCC 19795 | ? | - |
? | |
UDP-alpha-D-glucose + vancomycin aglycone | - |
Amycolatopsis orientalis | UDP + devancoaminyl vancomycin | - |
? | |
UDP-alpha-D-glucose + vancomycin aglycone | - |
Amycolatopsis orientalis ATCC 19795 | UDP + devancoaminyl vancomycin | - |
? |
Synonyms | Comment | Organism |
---|---|---|
GtfE | - |
Amycolatopsis orientalis |